Early Serum Carcinoembryonic Antigen Reduction Predicts Tumor Shrinkage and Overall Survival in Colorectal Cancer Patients with Distant Metastasis, after Primary Surgery Followed by Mfolfox6 Plus Bevacizumab Treatment